Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck

Clinical trial NCT02624999 · WITHDRAWN

Trial details

NCT number: NCT02624999
Sponsor: Mirror Biologics, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma Head and Neck

Start date: 2016-12-01
Primary completion: 2016-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.